Identification and in silico analysis of GALNS mutations causing Morquio A syndrome in eight consanguineous families

This is the first comprehensive study on molecular analysis of patients with Morquio A syndrome from Pakistan that reports four novel mutations with their structural and functional consequences.

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Genetic deficiency of N-acetylgalactosamine-6-sulfate sulfatase (GALNS) due to mutations in the GALNS gene results in the pathogenesis of Morquio A syndrome.

📊

Key Findings & Data:To date, more than 200 mutations have been reported in GALNS, resulting in variable clinical features.

💡

Conclusion & Impact:This is the first comprehensive study on molecular analysis of patients with Morquio A syndrome from Pakistan that reports four novel mutations with their structural and functional consequences.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

Genetic deficiency of N-acetylgalactosamine-6-sulfate sulfatase (GALNS) due to mutations in the GALNS gene results in the pathogenesis of Morquio A syndrome. To date, more than 200 mutations have been reported in GALNS, resulting in variable clinical features. For this reason, bioinformatics analysis of these mutations is important to determine their effect on the structure and functions of the protein and to establish a correlation between genotype and phenotype. In the present study, eight Pakistani consanguineous families with Morquio A syndrome were clinically and genetically evaluated. Linkage analysis followed by sequence analysis of the gene detected four novel (p.Phe216Ser, p.Met38Arg, p.Ala291Ser, p.Glu121Argfs*37) and two reported (p.Pro420Arg, p.Arg386Cys) mutations in the eight families. In silico structural and functional analysis predicted that these mutations disrupt the function of GALNS protein through fluctuating its three-dimensional structure, stability, and binding affinity and produce severe phenotypes. This is the first comprehensive study on molecular analysis of patients with Morquio A syndrome from Pakistan that reports four novel mutations with their structural and functional consequences.

🔖

Cite This Article

ULLAH, M. I., ULLAH, I., NASIR, A., MEHMOOD, S., AHMED, S., ULLAH, A., AZIZ2, A., SHAH, K., KHAN, S., HASSAN, M. J., AHMAD, W., RAZA, S. I. (2022). Identification and in silico analysis of GALNS mutations causing Morquio A syndrome in eight consanguineous families. Turkish Journal of Biology, Cilt: 41 - Sayı: 3, 458–468. https://ajindex.com/articles/600277

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (13)

Akhavan S, Miteva MA, Villoutreix BO, Venisse L, Peyvandi F, Mannucci PM, Guillin MC, Bezeaud A (2005). A critical role for Gly25 in the B chain of human thrombin. J Thromb Haemost 3: 139-145.
DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA, Hanna M et al (2011). A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43: 491-498.
Dill KA, Ozkan SB, Weikl TR, Chodera JD, Voelz VA (2007). The protein folding problem: when will it be solved? Curr Opin Struct Biol 17: 342-346.
Dobson CM (2003). Protein folding and misfolding. Nature 426: 884-890.
Dunker AK, Brown CJ, Lawson JD, Iakoucheva LM, Obradović Z (2002). Intrinsic disorder and protein function. Biochemistry 41: 6573-6582.
Gnad F, Baucom A, Mukhyala K, Manning G, Zhang Z (2013). Assessment of computational methods for predicting the effects of missense mutations in human cancers. BMC Genomics 14 (Suppl 3): S7. Harmatz P, Mengel KE, Giugliani R, Valayannopoulos V, Lin SP, Parini R, Guffon N, Burton BK, Hendriksz CJ, Mitchell J et al (2013). The Morquio A Clinical Assessment Program: baseline results illustrating progressive, multisystemic clinical impairments in Morquio A subjects. Mol Genet Metab 109: 54-61.
Hendriksz CJ, Harmatz P, Beck M, Jones S, Wood T, Lachman R, Gravance CG, Orii T, Tomatsu S (2013). Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA. Mol Genet Metab 110: 54-64.
Irfanullah, Umair M, Khan S, Ahmad W (2015). Homozygous sequence variants in the NPR2 gene underlying Acromesomelic dysplasia Maroteaux type (AMDM) in consanguineous families. Ann Hum Genet 79: 238-244.
Jones R, Ruas M, Gregory F, Moulin S, Delia D, Manoukian S, Rowe J, Brookes S, Peters G (2007). A CDKN2A mutation in familial melanoma that abrogates binding of p16INK4a to CDK4 but not CDK6. Cancer Res 67: 9134-9141.
Karplus M, Kuriyan J (2005). Molecular dynamics and protein function. Proc Natl Acad Sci U S A 102: 6679-6685.
Khan S, Vihinen M (2010). Performance of protein stability predictors. Hum Mutat 31: 675-684.
Koukouritaki SB, Poch MT, Henderson MC, Siddens LK, Krueger SK, VanDyke JE, Williams DE, Pajewski NM, Wang T, Hines RN (2007). Identification and functional analysis of common human flavin-containing monooxygenase 3 genetic variants. J Pharmacol Exp Ther 320: 266-273.
Li H, Durbin R (2009). Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics, 25: 1